Taysha Gene Therapies, Inc. financial data

Symbol
TSHA on Nasdaq
Location
3000 Pegasus Park Drive, Suite 1430, Dallas, TX
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 217 % +64.4%
Debt-to-equity 283 %
Return On Equity -243 % -120%
Return On Assets -63.4 % +46.2%
Operating Margin -607 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 205M shares +218%
Common Stock, Shares, Outstanding 201M shares +213%
Entity Public Float 30.4M USD -66.9%
Common Stock, Value, Issued 2K USD +100%
Weighted Average Number of Shares Outstanding, Basic 233M shares +262%
Weighted Average Number of Shares Outstanding, Diluted 233M shares +262%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 12.9M USD -53.6%
Research and Development Expense 60.2M USD -2.56%
General and Administrative Expense 29.7M USD -3.36%
Operating Income (Loss) -78.1M USD +34.6%
Nonoperating Income (Expense) -36.2M USD -712%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -114M USD +7.66%
Earnings Per Share, Basic -0.49 USD/shares +78.4%
Earnings Per Share, Diluted -0.49 USD/shares +78.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 173M USD +283%
Other Assets, Current 206K USD -59.6%
Assets, Current 178M USD +230%
Property, Plant and Equipment, Net 10.5M USD -25.6%
Operating Lease, Right-of-Use Asset 8.97M USD -13.3%
Other Assets, Noncurrent 288K USD -5.26%
Assets 200M USD +146%
Accounts Payable, Current 8.72M USD -19%
Employee-related Liabilities, Current 2.89M USD +40.8%
Liabilities, Current 34.2M USD -32.5%
Operating Lease, Liability, Noncurrent 18.1M USD -7.14%
Other Liabilities, Noncurrent 1.38M USD -64.8%
Liabilities 91.5M USD -22.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2.41M USD
Retained Earnings (Accumulated Deficit) -558M USD -25.8%
Stockholders' Equity Attributable to Parent 109M USD
Liabilities and Equity 200M USD +146%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.8M USD +1.92%
Net Cash Provided by (Used in) Financing Activities -370K USD -246%
Net Cash Provided by (Used in) Investing Activities -140K USD +96.4%
Common Stock, Shares Authorized 400M shares +100%
Common Stock, Shares, Issued 201M shares +213%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -20M USD +18.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.33M USD +18.1%
Deferred Tax Assets, Valuation Allowance 92M USD -8.94%
Deferred Tax Assets, Gross 94.3M USD -8.86%
Operating Lease, Liability 19.5M USD -6.3%
Depreciation 1.27M USD -5.81%
Payments to Acquire Property, Plant, and Equipment 140K USD -96.4%
Lessee, Operating Lease, Liability, to be Paid 29.1M USD -9.44%
Property, Plant and Equipment, Gross 14.1M USD -14%
Operating Lease, Liability, Current 1.38M USD +6.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.49M USD -17.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.91M USD -0.27%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.6M USD -15.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.58M USD +3.7%
Deferred Tax Assets, Operating Loss Carryforwards 47.4M USD +3.87%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.67M USD +3.73%
Operating Lease, Payments 2.74M USD +296%
Additional Paid in Capital 664M USD +63.4%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 10.5M USD -15.5%
Interest Expense 2.24M USD -56.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%